Efficacy News and Research

RSS
Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Sequential treatment with Entecavir and Lamivudine results in rebound of hepatitis B virus

Sequential treatment with Entecavir and Lamivudine results in rebound of hepatitis B virus

Immune therapy can control fertility in mammals

Immune therapy can control fertility in mammals

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Protox reports net loss of $4.5 million for year ended December 31, 2010

Protox reports net loss of $4.5 million for year ended December 31, 2010

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Pacira reports net loss of $7.0 million for quarter ended December 31, 2010

Cancer Commons researchers publish MDMM paper in PLoS ONE journal

Cancer Commons researchers publish MDMM paper in PLoS ONE journal

EPA approves Clorox DISPATCH disinfectant towels registration to fight against C. difficile

EPA approves Clorox DISPATCH disinfectant towels registration to fight against C. difficile

Abbott launches MitraClip system to treat MR in Australia

Abbott launches MitraClip system to treat MR in Australia

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

MonoSol Rx receives positive FDA feedback on 505(b)(2) pathway for Montelukast Sodium OSF

BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

BioSante completes patient enrollment in LibiGel Phase III trial against HSDD

Pharmasset commences PSI-7977 Phase 2b study against HCV

Pharmasset commences PSI-7977 Phase 2b study against HCV

Pathfinder cell-based therapy reverses diabetes in mouse model

Pathfinder cell-based therapy reverses diabetes in mouse model

Vexim granted FDA approval for COHESION bone cement

Vexim granted FDA approval for COHESION bone cement

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Navy sonar experts develop new medical device for stroke detection

Navy sonar experts develop new medical device for stroke detection

Orthopedic surgeons prefer Genzyme's 3-cycle hyaluronic-acid in the U.S., Europe

Orthopedic surgeons prefer Genzyme's 3-cycle hyaluronic-acid in the U.S., Europe

USPTO issues patent to Somaxon's Silenor food effect

USPTO issues patent to Somaxon's Silenor food effect

Positive results from Vertex VX-770 Phase 3 trial against CF

Positive results from Vertex VX-770 Phase 3 trial against CF

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.